ABOUT
The Swedish-American Life Science Summit 2011
The Swedish-American Life Science Summit 2011 is the seventh in a
series of summits, in an invitation-only format where we present a
program featuring some of the best known Life Science executives and
investors in the world.
The intense and exclusive two-day program includes high-level panel
discussions, insights from keynote speakers as well as a few selected
presentations by successful and promising Swedish companies.
It is our hope and ambition that the summit will serve to increase the
amount of cross-border business between the largest market in the
world, the United States, and one of the most important Life Science
industry centers in Europe, Sweden.
In addition, over the last couple of years the summit has taken on an
increasingly global nature, making the summit a true reflection of the
Life Science industry today.
Chairman & Senior Advisory Board
The people behind the Swedish-American Life Science Summit combine a long experience in the US pharmaceutical industry and Wall Street with today’s financial services within the field of Life Science in both countries.
Chairman
Barbro C. Ehnbom has been a pioneer in the Life
Science industry throughout her whole career. She was one of the first
female executives in several US pharmaceutical companies, a top analyst
in Wall Street, followed by many years of investment banking. As a long
time board member of the Swedish-American Chamber of Commerce and
Chairman Emeritus of the Swedish Economist Group in New York, she has
30 years experience in organizing events between Sweden and the U.S.,
not only in the commercial field but also in academics, music, the arts
and social entrepreneurship.
View Curriculum
Vitae »
View article
from Dagens Industri (pdf, 90Kb) »
Learn more
about The Female Economist of the Year Scholarship »
Senior Advisor
Frederick Frank is Vice Chairman of Peter J.
Solomon Company. Mr. Frank brings to the summit over forty-five years
of experience. Before joining Peter J. Solomon Company Mr. Frank was
Vice Chairman of Lehman Brothers and Barclays Capital. Prior to joining
Lehman Brothers he was Director of research and a Director of Smith,
Barney & Co. Inc. He serves on the Board of Directors of several
public companies and has provided investment banking services to an
extensive number of companies in the pharmaceutical, biotechnology,
healthcare service providers, medical device and nutraceutical
industries, and has been involved in hundreds of financings and merger
and acquisition transactions in the global health care industry.
View article from Biotech Sweden
(hi-res jpg, 2Mb) »
Senior Advisor
Dr. Hans Wigzell , MD, Ph. D. is Professor emeritus
in Immunology at the Department of Microbiology, Tumour and Cell
Biology at Karolinska Institutet since 2005. He is Chairman of
Karolinska Development AB and board member of Swedish Orphan Biovitrum
and a member of the Royal Swedish Academy of Sciences and the Royal
Swedish Academy of Engineering Sciences. Dr. Wigzell was the President
of Karolinska Institutet 1995-2003. From 1986 to 1991 he was head of
first the National Bacteriological Laboratory and then its successor
Swedish Institute for Infectious Disease Control. He is a member of the
Board of the Karolinska Development AB (Chairman), RaySearch AB,
Humabs, Intercell AG and AVIBiopharma as well as Chairman of Stockholm
School of Entrepreneurship.
Senior Advisor
Håkan Åström is the Chairman of Orexo AB, Ferrosan
Holding AS, Affibody Holding AB and PledPharma AB and previously
Swedish Orphan Biovitrum AB and Topotarget AS. He is also a board
member Rhenman & Partner Asset Management. Previously Mr. Åström
was the CEO of Travenol AB (Baxter Inc.), Astra Pharmaceuticals Ltd and
Kabi Pharmacia AB. He was the Head of Strategy and Communication of
Pharmacia Corporation and the CEO of Pharmacia AB 1997 – 2003. He was
also a board member of Karolinska Institutet 2004-2010. Mr. Åström is
Med Dr h.c. at the Sahlgrenska Academy, University of Gothenburg.
Program Advisor
Program Advisor
Lena Tibell is Founder & Managing Partner of
Tibell & Associates, a consultancy firm within Life Science
Business Management. She has over 20 years experience of International
Sales & Marketing and Business Management in Life Science industry
plus 10 years in Medical research and Drug analysis. Her experience
covers Business Strategies, Market Assessments, Product Development and
Launch, as well as Clinical Evaluations. Lena has senior competence in
working with Distributors and Sales organizations, as well as
Starting-up and Re-organizing sales companies. Prior to starting Tibell
& Associates, she held positions as Business Manager at Hudson RCI
and Louis Gibeck, Marketing Manager at Pharmacia Biotech and Clinical
Development Engineer at a Swedish University Hospital.
Administration SALSS 2011
Project Manager
Charlotte Staf is a Master student in Finance at the
Stockholm School of Economics. Charlotte has worked for ACCESS Health
International in India and Singapore, and for the Global Fund to fight
AIDS, Tuberculosis and Malaria in Swaziland. She is the founder and
president of the global non-profit student organization 180 Degrees
Consulting and has lead projects in Kenya, Tanzania, Russia and India.
In addition, Charlotte has lived and studied in India and Australia.
New York Coordinator
Freja Langert-Gidén holds an MSc in Business and
Administration and a BA in Art History from the University of
Stockholm. She managed the Swedish-American Life Science Summit 2008.
Prior to joining the SALSS 2011 team, Freja worked at the Swecare
Foundation in Stockholm, organizing and managing health care forums at
amongst others the House of Sweden in Washington D.C. and the Swedish
Embassy in Tokyo, Japan.
Stockholm Coordinator
Jonas Månsson has several years of experience in the
event management industry, both in Sweden and abroad. Most recently, he
was the Project Manager of the prestigious Female Economist of the Year
Scholarship Gala at Stockholm School of Economics. Jonas is also a
professional singer and fluent in five languages.
